Simran Farms Limited has successfully completed the allotment of 10,18,300 equity shares following its Board of Directors meeting held on March 30, 2026. The company's board approved the conversion of warrants into equity shares at an issue price of Rs 155/- per share, including a premium of Rs 145/- per share, after receiving the remaining 75% subscription amount from warrant holders.

Board Meeting Outcome

The board meeting, which commenced at 10.45 AM and concluded at 11.45 AM on March 30, 2026, addressed the previously scheduled agenda items. The meeting was held at the company's registered office in Indore, Madhya Pradesh, in compliance with SEBI regulations.

Share Allotment Details

The board approved the allotment of 10,18,300 equity shares through warrant conversion, with beneficiaries including members of the promoter group and non-promoter persons. The warrant holders exercised their conversion rights upon payment of the balance 75% consideration amount totaling Rs 11,83,77,375/-.

Major Allottees

The allotment included significant allocations to promoter group members and non-promoter individuals. Harpal Singh Bhatia received the largest allocation of 1,53,385 shares, while non-promoter Ashwani Chowdhry was allotted 2,00,000 shares.

Capital Structure Impact

Pursuant to the allotment, the company's issued, subscribed and paid-up capital has increased from Rs 3,79,17,000/- to Rs 4,81,00,000/-, consisting of 48,10,000 fully paid-up equity shares of Rs 10/- each. The newly allotted shares will rank pari-passu with existing equity shares and will be subject to lock-in provisions as per SEBI (ICDR) Regulations.

Regulatory Compliance

The company has filed the board meeting outcome with BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additional details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, have been filed separately in both PDF and XBRL formats within the prescribed timeframe.

Simran Farms Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025, alongside significant board changes during a meeting held on February 14, 2026. The company, primarily engaged in poultry breeding and farming activities, reported mixed financial performance with notable improvements in quarterly results.

Financial Performance Overview

The company's standalone financial results show a significant improvement in quarterly performance. For Q3 FY26, Simran Farms reported a net profit of ₹109.42 lakhs compared to ₹12.89 lakhs in the corresponding quarter of the previous year, representing a substantial increase. However, the nine-month performance shows a decline, with net profit at ₹215.30 lakhs compared to ₹904.48 lakhs in the previous year.

Consolidated Results

The consolidated financial results, which include subsidiary Puregene Biotech Limited, show similar trends. Consolidated net profit for Q3 FY26 stood at ₹114.18 lakhs compared to ₹14.09 lakhs in the previous year's quarter. For the nine-month period, consolidated net profit was ₹225.74 lakhs against ₹910.53 lakhs in the corresponding period of the previous year.

Board Changes and New Director Appointment

The board approved significant changes in its composition with Mrs. Sherry Mac (DIN: 10736916) resigning from her position as Non-Executive Woman Independent Director with effect from the close of business hours on February 14, 2026. Based on the recommendation of the Nomination and Remuneration Committee, the board appointed Adv. Deepika Sharma (DIN: 11543076) as Additional Director under the category of Non-Executive Woman Independent Director for a five-year term from February 14, 2026, to February 13, 2031, subject to shareholder approval.

Committee Reconstitution

Following the board changes, all statutory committees have been reconstituted with the new director. The company has confirmed that Adv. Deepika Sharma has not been debarred from holding the office of Director by virtue of any SEBI order or any other authority.

Operational Highlights

The company's revenue from operations increased to ₹23,262.48 lakhs in Q3 FY26 from ₹18,846.27 lakhs in the corresponding quarter of the previous year. Total expenses for the quarter were ₹23,168.36 lakhs, with raw material consumption being the major component at ₹19,595.92 lakhs. The company maintained its focus on poultry breeding and farming activities, with no identifiable operating segments requiring separate disclosure under IND AS-108.

Corporate Compliance

The financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors. The results have been reviewed by statutory auditors Khandelwal Kakani & Company in accordance with Regulation 33 of the SEBI Listing Regulations. The company confirmed that all necessary due diligence was exercised to ensure the financial results provide a true and fair view of its affairs. The board meeting commenced at 4:15 PM and concluded at 6:45 PM on February 14, 2026.